Sexual wellness startup Allo Health will use the capital to expand its clinic network, strengthen technological capabilities, ...
Bengaluru-based Allo Health raises INR 16 Cr in Pre-Series A round led by Zerodha's Rainmatter to expand clinic network and ...
Allo Health raises Rs. 16 crore to expand India’s largest sexual health ecosystem: Our Bureau, Bengaluru Wednesday, March 12, 2025, 17:45 Hrs [IST] Allo Health, India’s leadin ...
March 03, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for ...
FDA has provided input on key elements of the SER-155 allo-HSCT clinical development plans including support for the proposed primary efficacy ...
Allogene Therapeutics is developing allogeneic CAR-T cells for cancer and autoimmune diseases. Read why I'm bullish on ALLO stock.
Cellistic, a pioneer in iPSC-based off-the-shelf cell therapy development and manufacturing services, announces the launch of its Allo Chassis™—ready-to-use, immune-cloaked iPSC cell lines ...
“We are encouraged by these latest data that demonstrate a powerful synergy between MiNK’s allo-iNKT cells, checkpoint inhibitors, and approved chemotherapy, sparking robust immune reactivation and ...
The following is a summary of “Prognostic impact of effusion in multiple body cavities after allogeneic hematopoietic stem cell transplantation,” published in the March 2025 issue of International ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback